| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |